MicroRNA miR-491-5p targeting both TP53 and Bcl-XL induces cell apoptosis in SW1990 pancreatic cancer cells through mitochondria mediated pathway

Molecules

Volumn 17, Issue 12, 2012, Pages 14733-14747

  Guo, Rong ^a   Wang, Yi ^a   Shi, Wei Ye ^a   Liu, Bin ^a   Hou, Sheng Qi ^a   Liu, Li ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Bcl xL; MiR491 5p; PI 3K Akt; STAT3; TP53

Indexed keywords

BCL2L1 PROTEIN, HUMAN; MICRORNA; MIRN491 MICRORNA, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL X; PROTEIN P53; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TP53 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; PANCREAS TUMOR; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; AMINO ACID SEQUENCE; APOPTOSIS; BCL-X PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; PANCREATIC NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84871591875     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules171214733     Document Type: Article

References (31)

1. Chen, C.Z. MicroRNAs as oncogenes and tumor suppressors. N. Engl. J. Med. 2005, 353, 1768-1771.
2. Elmore, S. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 2007, 35, 495-516.
3. Ow, Y.-L.P.; Green, D.R.; Hao, Z.; Mak, T.W. Cytochrome c: Functions beyond respiration. Nat. Rev. Mol. Cell Biol. 2008, 9, 532-542.
4. Nagata, S. Fas ligand-induced apoptosis. Annu. Rev. Genet. 1999, 33, 29-55.
5. Peter, M.E.; Krammer, P.H. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 2003, 10, 26-35.
6. Acehan, D.; Jiang, X.; Morgan, D.G.; Heuser, J.E.; Wang, X.; Akey, C.W. Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation. Mol. Cell 2002, 9, 423-432.
7. Youle, R.J.; Strasser, A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9, 47-59.
8. Willis, S.N.; Fletcher, J.I.; Kaufmann, T.; van Delft, M.F.; Chen, L.; Czabotar, P.E.; Ierino, H.; Lee, E.F.; Fairlie, W.D.; Bouillet, P.; et al. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 2007, 315, 856-859.
9. Papaconstantinou, I.G.; Lykoudis, P.M.; Gazouli, M.; Manta, A.; Polymeneas, G.; Voros, D. A review on the role of microRNA in biology, diagnosis, and treatment of pancreatic adenocarcinoma. Pancreas 2012, 41, 671-677.
10. Zou, H.; Li, Y.; Liu, X.; Wang, X. An APAF-1.cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J. Biol. Chem. 1999, 274, 11549-11556.
11. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 2011, 60, 277-300.
12. Krejs, G.J. Pancreatic cancer: Epidemiology and risk factors. Dig. Dis. 2010, 28, 355-358.
13. Lowenfels, A.B.; Maisonneuve, P. Epidemiology and risk factors for pancreatic cancer. Best Pract. Res. Clin. Gastroenterol. 2006, 20, 197-209.
14. Wang, J.; Sen, S. MicroRNA functional network in pancreatic cancer: From biology to biomarkers of disease. J. Biosci. 2011, 36, 481-491.
15. Schultz, N.A.; Werner, J.; Willenbrock, H.; Roslind, A.; Giese, N.; Horn, T.; Wojdemann, M.; Johansen, J.S. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod. Pathol. 2012, 25, 1609-1622.
16. Bloomston, M.; Frankel, W.L.; Petrocca, F.; Volinia, S.; Alder, H.; Hagan, J.P.; Liu, C.G.; Bhatt, D.; Taccioli, C.; Croce, C.M. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007, 297, 1901-1908.
17. Szafranska, A.E.; Davison, T.S.; John, J.; Cannon, T.; Sipos, B.; Maghnouj, A.; Labourier, E.; Hahn, S.A. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26, 4442-4452.
18. Jiao, L.R.; Frampton, A.E.; Jacob, J.; Pellegrino, L.; Krell, J.; Giamas, G.; Tsim, N.; Vlavianos, P.; Cohen, P.; Ahmad, R.; et al. MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One 2012, 7, e32068.
19. Ali, S.; Saleh, H.; Sethi, S.; Sarkar, F.H.; Philip, P.A. MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer. Br. J. Cancer 2012, 107, 1354-1360.
20. Papaconstantinou, I.G.; Manta, A.; Gazouli, M.; Lyberopoulou, A.; Lykoudis, P.M.; Polymeneas, G.; Voros, D. Expression of MicroRNAs in Patients With Pancreatic Cancer and Its Prognostic Significance. Pancreas 2012, doi:10.1097/MPA.0b013e3182592ba7.
21. Nakano, H.; Miyazawa, T.; Kinoshita, K.; Yamada, Y.; Yoshida, T. Functional screening identifies a microRNA, miR-491 that induces apoptosis by targeting Bcl-X(L) in colorectal cancer cells. Int. J. Cancer 2010, 127, 1072-1080.
22. Pinto, M.; Orzaez Mdel, M.; Delgado-Soler, L.; Perez, J.J.; Rubio-Martinez, J. Rational design of new class of BH3-mimetics as inhibitors of the Bcl-xL protein. J. Chem. Inf. Model. 2011, 51, 1249-1258.
23. Wang, Z.X.; Yang, J.S.; Pan, X.; Wang, J.R.; Li, J.; Yin, Y.M.; De, W. Functional and biological analysis of Bcl-xL expression in human osteosarcoma. Bone 2010, 47, 445-454.
24. Liu, R.; Page, C.; Beidler, D.R.; Wicha, M.S.; Nunez, G. Overexpression of Bcl-x(L) promotes chemotherapy resistance of mammary tumors in a syngeneic mouse model. Am. J. Pathol. 1999, 155, 1861-1867.
25. Grad, J.M.; Zeng, X.R.; Boise, L.H. Regulation of Bcl-xL: A little bit of this and a little bit of STAT. Curr. Opin. Oncol. 2000, 12, 543-549.
26. Tang, X.; Downes, C.P.; Whetton, A.D.; Owen-Lynch, P.J. Role of phosphatidylinositol 3-kinase and specific protein kinase B isoforms in the suppression of apoptosis mediated by the Abelson protein-tyrosine kinase. J. Biol. Chem. 2000, 275, 13142-13148.
27. Catlett-Falcone, R.; Landowski, T.H.; Oshiro, M.M.; Turkson, J.; Levitzki, A.; Savino, R.; Ciliberto, G.; Moscinski, L.; Fernandez-Luna, J.L.; Nunez, G.; et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity 1999, 10, 105-115.
28. Karnauskas, R.; Niu, Q.; Talapatra, S.; Plas, D.R.; Greene, M.E.; Crispino, J.D.; Rudin, C.M. Bcl-x(L) and Akt cooperate to promote leukemogenesis in vivo. Oncogene 2003, 22, 688-698.
29. Qian, J.; Zou, Y.; Rahman, J.S.; Lu, B.; Massion, P.P. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung. Mol. Cancer Ther. 2009, 8, 101-109.
30. Zhang, J.; Du, Y.Y.; Lin, Y.F.; Chen, Y.T.; Yang, L.; Wang, H.J.; Ma, D. The cell growth suppressor, mir-126, targets IRS-1. Biochem. Biophys. Res. Commun. 2008, 377, 136-140.
31. Ishiyama, M.; Miyazono, Y.; Sasamoto, K.; Ohkura, Y.; Ueno, K. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta 1997, 44, 1299-1305.